Literature DB >> 1385357

Complement neoantigen and vitronectin are components of plaques in amyloid AL neuropathy.

G L Zanusso1, G Moretto, B Bonetti, S Monaco, N Rizzuto.   

Abstract

We studied three patients with late onset, chronic sensorimotor and autonomic neuropathy in course of plasma cell dyscrasia with Bence Jones proteinuria. Histopathological findings of nerve biopsies consisted in diffuse loss of myelinated and unmyelinated fibers associated with perivascular deposits of amorphous material with physico-chemical and ultrastructural features of amyloid. By immunohistochemistry, light chains of the same type as Bence Jones protein, components of the classic and lytic pathways of the complement and vitronectin were detected at the level of amyloid nodules. The colocalization of complement neoantigen and vitronectin suggests that this complex derives from the circulation. The elucidation of the chemical composition of amyloid might shed some light in the pathogenesis of these disorders.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385357     DOI: 10.1007/bf02230870

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  28 in total

Review 1.  Alzheimer's disease from the perspective of the systemic and localized forms of amyloidosis.

Authors:  E M Castaño; B Frangione
Journal:  Brain Pathol       Date:  1991-07       Impact factor: 6.508

2.  Immunohistochemistry of amyloid-related neuropathies.

Authors:  U Horn; H H Goebel; S Störkel; J Bohl; E Thomas; W Schlote; G Budzilovich
Journal:  Clin Neuropathol       Date:  1991 Sep-Oct       Impact factor: 1.368

3.  The ultrastructural localization of sulfated proteoglycans is identical in the amyloids of Alzheimer's disease and AA, AL, senile cardiac and medullary carcinoma-associated amyloidosis.

Authors:  I D Young; J P Willmer; R Kisilevsky
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 4.  Familial amyloidotic polyneuropathy.

Authors:  M D Benson
Journal:  Trends Neurosci       Date:  1989-03       Impact factor: 13.837

5.  Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.

Authors:  F Coria; E Castaño; F Prelli; M Larrondo-Lillo; S van Duinen; M L Shelanski; B Frangione
Journal:  Lab Invest       Date:  1988-04       Impact factor: 5.662

Review 6.  Human amyloidosis, Alzheimer disease and related disorders.

Authors:  E M Castaño; B Frangione
Journal:  Lab Invest       Date:  1988-02       Impact factor: 5.662

Review 7.  Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-12       Impact factor: 91.245

8.  Beta-2 microglobulin is an amyloidogenic protein in man.

Authors:  P D Gorevic; T T Casey; W J Stone; C R DiRaimondo; F C Prelli; B Frangione
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

9.  The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis.

Authors:  J T Kissel; R K Halterman; K W Rammohan; J R Mendell
Journal:  Arch Neurol       Date:  1991-01

10.  Variant apolipoprotein AI as a major constituent of a human hereditary amyloid.

Authors:  W C Nichols; F E Dwulet; J Liepnieks; M D Benson
Journal:  Biochem Biophys Res Commun       Date:  1988-10-31       Impact factor: 3.575

View more
  1 in total

1.  MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits.

Authors:  Martin Winter; Andreas Tholey; Sandra Krüger; Hartmut Schmidt; Christoph Röcken
Journal:  J Histochem Cytochem       Date:  2015-06-22       Impact factor: 2.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.